100% Secure Payments
Tender Details
- Country: Germany
- Summary: Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Interferon Beta-1A (Avonex(R))
- DET Ref No: 83054965
- Deadline: 09 May 2025
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: Public
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 293843-2023
- Purchaser's Detail :
- Description :
- §130a paragraph 8 SGB V enables the health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements on the drugs to be dispensed at the expense of the statutory KK. The GWQ is registered as a society for economy and quality at KK according to § 130a Abs. 8 S. 5 SGB V for their Aknational and customer checkouts. With regard to the relevant legal regulations for the award of public contracts, a regular process of active ingredient-related, formal award procedures takes place according to the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until IWhen new drug discount agreements come into force, the GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies as part of the open house procedure for preparations with the u. a. complete active substance. The earliest contract start date is July 1st, 2023.
Doc Title: Pharmaceuticalproducts
Contract Type: Supplies - Documents :
Purchaser : GWQ SERVICEPLUS AG
Address : acting for the statutory health insurance companies specified under VI 2.)
Town : Duesseldorf
NUTS code : DE - Germany
Postal Code : 40549
Contact Point : GWQ ServicePlus AG
Phone : 49 211758498-0
Fax : 49 211758498 -48
Email :bieteranfrage@gwq-serviceplus.de
URL :http://www.gwq-serviceplus.de
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
